Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients presenting with a skin abscess that requires surgical drainage (induration ≥ 1 cm in diameter)~* minimally invasive surgical technique with the insertion of a subcutaneous drain can be utilized on the patient~Exclusion Criteria:~* patients requiring immediate hospitalization~* patients who have received 2 or more doses of antibiotics in the previous 36 hours~* patients with diabetes, sickle-cell disease, an immuno-compromising disease, an underlying medical condition predisposing the patient to frequent hospitalizations or medical visits, or indwelling catheters or percutaneous medical devices~* patients with a concurrent, non-abscess infection~* patients with an allergy to Trimethoprim-sulfamethoxazole

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- 10 days of Trimethoprim-Sulfamethoxazole (Type: ACTIVE_COMPARATOR): Oral Trimethoprim-Sulfamethoxazole dosed at 10 mg Trimethoprim/kg/day divided twice a day, to a maximum of 640 mg Trimethoprim/day
- 3 days of Trimethoprim-Sulfamethoxazole (Type: EXPERIMENTAL): Oral Trimethoprim-Sulfamethoxazole dosed at 10 mg Trimethoprim/kg/day divided twice a day, to a maximum of 640 mg Trimethoprim/day

Based on this trial design, predict the completion outcome and termination type (if applicable).